Meeting
2022 ASCO Gastrointestinal Cancers Symposium
“Super massive” intrahepatic cholangiocarcinoma: Potential role of radiation therapy.
Authors
Joseph Abi Jaoude
The University of Texas MD Anderson Cancer Center, Houston, TX
Joseph Abi Jaoude , Brian De , Humberto R Nieves Jiménez , Rituraj Upadhyay , Cullen M. Taniguchi , Eugene Jon Koay , Ethan B. Ludmir
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
DOI
10.1200/JCO.2022.40.4_suppl.567
Abstract #
567
Poster Bd #
H7
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC).
First Author: Andrea Cercek
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Has management of locally advanced intrahepatic cholangiocarcinoma evolved with the evidence? Trends and practice patterns from the National Cancer Database.
First Author: Lauren E. Schleimer
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Comparison of liver-directed combined radiotherapy versus sorafenib in patients with locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: An Asian Liver Radiotherapy Group Study.
First Author: Jinsil Seong